PTPRC and neoplasm: CD45+EPCs, following activation by tumor growth-associated extramedullary hematopoiesis, aggregate in the spleen to become the predominant population, outnumbering regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs).